← Leaderboards
Animesh Dhar
University Of Kansas Medical Center
$1,065,230
Attributed
$1,065,230
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $543.2K · FY2011–13$1M$750K$500K$250K$0
'11
'12
'13
Funding mix
By agency
NIH$1,065,230 · 2
By mechanism
R01$1,065,230 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- John D Robertson$336,120
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationMouse ModelMalignant NeoplasmsPancreatic Cancer CellsSignal TransductionEventIn VitroMalignant Neoplasm Of PancreasMolecularNeoplasm MetastasisRegulationSignal PathwayTumor GrowthXenograft ProcedureApoptosisGrowthIn VivoCell CycleMediatingChemopreventive AgentCell GrowthEpidermal Growth Factor ReceptorAntitumor AgentEsters
Grant awards (4)
Pancreatic Cancer: Crocetin as a Novel Therapeutic Approach$246,764
R01 · FY2013 · CA · contact PI
Chemoprevention of Pancreatic Cancer by EGCG$280,680
R01 · FY2012 · CA · contact PI
Pancreatic Cancer: Crocetin as a Novel Therapeutic Approach$262,515
R01 · FY2012 · CA · contact PI
Pancreatic Cancer: Crocetin as a Novel Therapeutic Approach$275,271
R01 · FY2011 · CA · contact PI